ReviewDrugs & aging2004
The application of fuzzy logic to the prescription of antithrombotic agents in the elderly.
Review in Drugs & aging, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 16 citations in OpenAlex.
- Article
- Machine Learning and Antibiotic Management.Antibiotics (Basel, Switzerland) · 2022Article
- Practice guidelines and clinical risk assessment models: is it time to reform?BMC medical informatics and decision making · 2011Article
- Fuzzy logic: A "simple" solution for complexities in neurosciences?Surgical neurology international · 2011Article
- How artificial intelligence tools can be used to assess individual patient risk in cardiovascular disease: problems with the current methods.BMC cardiovascular disorders · 2006Article
- Medical concepts related to individual risk are better explained with "plausibility" rather than "probability".BMC cardiovascular disorders · 2005Article
- Fuzzy logic and continuous cellular automata in warfarin dosing of stroke patients.Current treatment options in cardiovascular medicine · 2005Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The prescription of antithrombotic agents in the elderly depends, to certain degree, on the identity of the unique individual elderly patient. This dependence cannot be captured by viewing the patient as belonging to a group, but rather by viewing age in the context of unique individual biology. This context is historical, physiological, psychological, and time- and location-dependent. The group-based approach to patient therapy is found in evidence-based medicine, typified by the large double-blind randomised clinical trial from which clinical recommendations are defined. An alternative approach to capturing the unique context of each patient is based using fuzzy logic and mathematics. In particular, the fuzzy subsethood theorem of Kosko has direct application here. A new measure of clinical efficiency, K, derived from the fuzzy subsethood theorem has redefined the clinical significance of age. In particular, the causal role of age in any one patient's response to therapy is to unique degree for that patient. This is because the causal measure K accounts for the role of known and unknown contextual factors of the patient, most of which are unknown, in defining clinical effect in any specific patient. Thus, we have shown mathematically why 'age', or being 'elderly', is only one factor to be taken into consideration when therapeutic decisions regarding antithrombotic therapy are made in any given patient. This is contrary to the group-based approach of evidence-based medicine, where age has the same therapeutic significance for all patients. This is because any hypothesis of evidence-based medicine is group-based and cannot be extrapolated to the individual patient. Such extrapolation has to be personalized through the expertise of the physician. The physician takes into account all the factors not considered in any therapeutic group-based trial which apply to his specific patient. These considerations take into account past experience with that patient. An example of the effect of age on the patient and his/her therapeutic context is provided which shows how age affects different patients to different degree using the fuzzy causal measure K. The purpose of this exercise is to show that there is mathematical support for the argument that individualization of patient therapy by expert decision has measurable clinical significance. What is different here is that measure stick is not probabilistic but fuzzy-mathematic based.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.